Minireview: Overview of the renin-angiotensin system - An endocrine and paracrine system

被引:429
作者
Lavoie, JL
Sigmund, CD [1 ]
机构
[1] Univ Iowa, Roy J & Lucille A Carver Coll Med, Med Educ & Biomed Res Facil 3181B, Dept Internal Med, Iowa City, IA 52242 USA
[2] Univ Iowa, Roy J & Lucille A Carver Coll Med, Med Educ & Biomed Res Facil 3181B, Dept Physiol & Biophys, Iowa City, IA 52242 USA
关键词
D O I
10.1210/en.2003-0150
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since the discovery of renin as a pressor substance in 1898, the renin-angiotensin (RAS) system has been extensively studied because it remains a prime candidate as a causative factor in the development and maintenance of hypertension. Indeed, some of the properties of the physiologically active component of the RAS, angiotensin II, include vasoconstriction, regulation of renal sodium and water absorption, and increasing thirst. Initially, its affect on blood pressure was thought to be mediated primarily through the classical endocrine pathway; that is, the generation of blood-borne angiotensin with actions in target tissues. More recently, however, it has become appreciated that a local autocrine or paracrine RAS may exist in a number of tissues, and that these may also play a significant role in regulating blood pressure. Some of the difficulties in studying tissue RAS stem from the limitations of pharmacology in not differentiating between RAS products made systemically from those synthesized locally. However, the development of transgenic animals with highly specific promoters to target the RAS to specific tissues provided important tools to dissect these systems. Thus, this minireview will discuss recent advances in understanding the relationship between endocrine and paracrine (tissue) RAS using transgenic models.
引用
收藏
页码:2179 / 2183
页数:5
相关论文
共 56 条
[1]   Tissue renin-angiotensin systems:: new insights from experimental animal models in hypertension research [J].
Bader, J ;
Peters, J ;
Baltatu, O ;
Müller, DN ;
Luft, FC ;
Ganten, D .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2001, 79 (2-3) :76-102
[2]   TONIN, ANGIOTENSINII SYSTEM - REVIEW [J].
BOUCHER, R ;
DEMASSIEUX, S ;
GARCIA, R ;
GENEST, J .
CIRCULATION RESEARCH, 1977, 41 (04) :26-29
[3]  
Brunner HR, 1979, ANN INTERN MED, V2, P1317
[4]   THE BRAIN RENIN-ANGIOTENSIN SYSTEM - LOCALIZATION AND GENERAL SIGNIFICANCE [J].
BUNNEMANN, B ;
FUXE, K ;
GANTEN, D .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 :S51-S62
[5]   DIFFERENTIAL EXPRESSION OF ANGIOTENSIN RECEPTOR 1A AND 1B IN MOUSE [J].
BURSON, JM ;
AGUILERA, G ;
GROSS, KW ;
SIGMUND, CD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (02) :E260-E267
[6]   Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function [J].
Carey, RM ;
Wang, ZQ ;
Siragy, HM .
HYPERTENSION, 2000, 35 (01) :155-163
[7]   Targeting deletion of angiotensin type 1B receptor gene in the mouse [J].
Chen, XM ;
Li, WG ;
Yoshida, H ;
Tsuchida, S ;
Nishimura, H ;
Takemoto, F ;
Okubo, S ;
Fogo, A ;
Matsusaka, T ;
Ichikawa, I .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1997, 272 (03) :F299-F304
[8]   ANGIOTENSIN-II - A POWERFUL CONTROLLER OF SODIUM-TRANSPORT IN THE EARLY PROXIMAL TUBULE [J].
COGAN, MG .
HYPERTENSION, 1990, 15 (05) :451-458
[9]  
COLEMAN JKM, 1992, FASEB J, V6, pA981
[10]   FACILITATION OF NORADRENALINE RELEASE FROM SYMPATHETIC-NERVES THROUGH ACTIVATION OF ACTH RECEPTORS, BETA-ADRENOCEPTORS AND ANGIOTENSIN-II RECEPTORS [J].
COSTA, M ;
MAJEWSKI, H .
BRITISH JOURNAL OF PHARMACOLOGY, 1988, 95 (03) :993-1001